Magnesium Trisilicate

Quick links to important sections

Magnesium Trisilicate

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Magnesium Trisilicate

Quick Facts

Property Description
Active Ingredient Magnesium Trisilicate ( Mg2Si3O8cdot xH2O )
Form Tablet, Liquid Suspension
Pharmacological Class Antacid
General Purpose Symptomatic relief of excess stomach acid
Origin Synthetic Inorganic Compound

Magnesium Trisilicate: Chemical Definition and Pharmacological Classification

Magnesium Trisilicate is a synthetic inorganic compound classified pharmacologically as an antacid, primarily used for the symptomatic relief of conditions related to excessive stomach acid. The active ingredient is chemically defined as a hydrated compound of magnesium and silicon oxides. This substance is administered via the oral route and is available for patient use primarily in two dosage forms: compressed tablets and as a liquid suspension or mixture.

The core function of this compound is to act as a mild base, initiating a neutralisation reaction within the highly acidic environment of the stomach to elevate the gastric pH level. It is used as an antacid, including for the management of peptic ulcers. The unique colloidal nature of this compound is a key differentiating factor, often employed in over-the-counter (OTC) formulations, making it a commonly recognized agent for managing acid-related discomfort.


General Purpose and Sustained Action Profile

The general purpose of using Magnesium Trisilicate is to provide effective, long-lasting symptomatic relief for the discomfort associated with excessive gastric acidity. Its sustained action profile is characterized by a slow onset but a distinctively long-lasting duration of effect compared to many fast-acting antacids.

This prolonged benefit stems from a dual mechanism: immediate acid neutralization followed by the slow release and precipitation of colloidal silica. This silica forms a protective, gel-like layer that acts as a mucosal protector, physically shielding the lining of the stomach and esophagus from further irritation by acid and digestive enzymes like pepsin. The compound is often utilized in combination products—for instance, with aluminum hydroxide—to achieve a balanced effect on gastrointestinal function while enhancing both acid reduction and sustained protection.

Regulatory References

  1. Antacids - StatPearls - NCBI Bookshelf

What side effects are possible with Magnesium Trisilicate?

Possible Side Effects and Safety Information: Magnesium Trisilicate

Magnesium trisilicate is generally considered safe for short-term use as an antacid when taken as directed. However, like all medications, it can cause side effects and requires certain precautions.

Common Side Effects

The most frequently reported side effect associated with magnesium-containing antacids, including magnesium trisilicate, is diarrhea. This is due to the osmotic activity of magnesium ions in the gut, which draws water into the intestines. This effect is often dose-dependent.

Less Common/Serious Side Effects

Prolonged or excessive use may lead to more serious concerns, particularly in individuals with pre-existing conditions:

  • Hypermagnesemia: High blood levels of magnesium are rare in people with normal kidney function. However, in patients with impaired renal function (kidney disease), the reduced ability to excrete magnesium can lead to hypermagnesemia. Symptoms can include low blood pressure, muscle weakness, confusion, and, in severe cases, respiratory depression or cardiac arrest.
  • Silica Kidney Stones: Very high, long-term intake has been associated with the formation of silica-based kidney stones.

Drug Interactions and Precautions

Magnesium trisilicate can interact with certain medications by reducing their absorption from the digestive tract. It should be taken at a different time (typically 2-4 hours apart) from drugs such as:

  • Tetracycline and quinolone antibiotics
  • Iron supplements
  • Certain heart medications (e.g., digoxin)
Patient Group Safety Consideration
Renal Impairment Use with caution; high risk of Hypermagnesemia.
Pregnancy/Lactation Consult a healthcare provider before use.
Long-Term Use Not recommended without medical supervision due to potential for electrolyte imbalance and stone formation.

Discontinue use and seek medical advice if symptoms persist or worsen, or if signs of hypermagnesemia develop.

Overdose and Emergency Response

The official regulatory profile for Magnesium Trisilicate overdose details manifestations related to systemic magnesium toxicity ( hypermagnesemia) and physical effects in the gastrointestinal tract. Documented presentations include diarrhoea, abdominal pain, vomiting, muscle weakness, drowsiness, and loss of tendon reflexes.

Overdose Manifestations Severe Outcomes
Hypotension, Thirst, Confusion Cardiac arrhythmias, Heart block, Respiratory depression

In the event of suspected overdose, regulators explicitly state the need to seek immediate medical attention or contact a poison control center or emergency room at once. The official management procedure requires discontinuing the medication and initiating symptomatic and supportive treatment. For severe magnesium poisoning, the treatment documented to reverse critical cardiac and respiratory effects is the intravenous administration of Calcium Gluconate.

Population-specific overdose notes emphasize that patients with renal impairment and the elderly are at higher risk for accumulation leading to severe hypermagnesemia or intestinal obstruction. The official context constraints confirm that interventions such as haemodialysis may be required for patients with renal function deficiency to clear excess components.

Therapeutic Uses of Magnesium Trisilicate

Quick Facts: Uses and Benefits

  • Relief Target: Heartburn and acid indigestion.
  • Support Domain: Management of symptoms associated with peptic ulcers.
  • Therapeutic Action: Helps to reduce excess stomach acidity and associated discomfort.

Magnesium trisilicate is a commonly available compound used to support the management of symptoms associated with excessive stomach acid. Its primary therapeutic domain is the relief of occasional heartburn and acid indigestion. The compound is also indicated as part of the overall therapeutic approach for addressing discomfort that may be associated with gastric and peptic ulcers.

This option functions to reduce the overall acidity within the stomach, which can help in the temporary management of symptoms such as sour stomach or general stomach upset. Magnesium trisilicate is frequently incorporated into combination products to support the neutralisation of gastric contents. Patients are encouraged to consult their healthcare professional for complete guidance on its appropriate use and to review comprehensive information regarding its indications and safety profile.

Eligibility and Restrictions for Use

Who can and cannot use Magnesium Trisilicate?

This section summarizes official regulatory information regarding eligibility for the use of Magnesium Trisilicate, often taken in combination with other antacids like Aluminum Hydroxide.

Contraindications (Must Not Use)

Magnesium Trisilicate is contraindicated (should not be used) in several patient populations due to the risk of severe harm or accumulation. These include individuals with severe renal impairment or kidney failure because of the risk of toxic accumulation of magnesium and aluminum (from combination products). It is also contraindicated in patients who are severely debilitated, those with hypophosphataemia, or those with symptoms suggesting bowel obstruction or severe abdominal pain.

Populations Requiring Caution or Restriction

Use requires special consideration and physician advice for specific groups. These include the elderly, who may be at higher risk for intestinal side effects, and children under 12 years for whom safety and efficacy may not be established. Caution is also advised during pregnancy and lactation, particularly avoiding use during the first trimester of pregnancy where possible. Patients with hereditary sugar intolerances (if the specific product contains relevant excipients) must also avoid use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Magnesium Trisilicate, as an antacid, primarily interacts with other substances through physicochemical mechanisms involving gastric pH alteration and cation binding. This activity results in a major pharmacokinetic interaction that decreases the systemic exposure of co-administered oral medications.

Exposure-Modifying Interactions

This antacid reduces the absorption and subsequent plasma levels of numerous essential medicines, including Quinolone and Tetracycline Antibiotics, Oral Bisphosphonates (e.g., Alendronate), Thyroid Hormones (e.g., Levothyroxine), and Digoxin. A significant reduction in the absorption of Oral Corticosteroids is also documented. Combining the antacid with oral Raltegravir is formally classified as a Contraindicated combination in regulatory documents due to the risk of reduced therapeutic effect.

Interaction Constraints and Population Risk

To mitigate the risk of reduced absorption, regulatory labeling mandates a mandatory timing separation rule: all other oral medications must be administered at least two hours apart from the antacid dose. A pharmacodynamic interaction exists with other Magnesium-containing preparations, increasing the additive systemic load and the risk of hypermagnesemia. This risk, along with the potential for aluminum toxicity (when combined with Citrates), is substantially heightened in patients with renal insufficiency.

Mechanism of Action

How Magnesium Trisilicate Works

Magnesium trisilicate, an inorganic salt, functions through non-systemic chemical and physical mechanisms confined to the gastrointestinal tract. It exhibits acid-neutralizing capacity and forms a physical mucosal barrier.


Acid Neutralization and Buffering

This compound demonstrates a delayed onset and extended duration of acid neutralization. Upon gastric administration, it reacts with hydrochloric acid (HCl) via a chemical cascade, yielding magnesium chloride, water, and silicic acid. The resultant silicic acid subsequently acts as a buffer, contributing to the maintenance of elevated gastric pH and effecting a physiologically relevant increase in gastric pH.


Cytoprotection and Pepsin Modulation

During neutralization, the silicic acid polymerizes into a gelatinous silica matrix. This viscous gel coats the mucosal surface of the esophagus and stomach. This physical barrier limits the interaction of gastric acid and pepsin with the mucosal epithelium. Furthermore, the pH elevation directly reduces the activity of the proteolytic enzyme pepsin, and the silica gel may physically adsorb and bind pepsin, resulting in decreased proteolytic activity within the gastric lumen.

Dosage and Administration Information

How to Use Magnesium Trisilicate

Magnesium Trisilicate use involves specific parameters concerning its route, preparation, and timing. The product is available for oral administration only, typically as tablets (often chewable) or as a liquid suspension.


Administration Scope

Entity Guideline or Requirement
Route of administration Oral administration only.
Dosing schedule Adult Dose: 10 mL to 20 mL of suspension, or 1 to 2 tablets.
Timing in relation to meals Dosing is taken between meals and at bedtime, or as required for symptomatic relief.
Preparation requirements Liquid preparations must be shaken well before measurement. Tablets, if chewable, must be thoroughly chewed.
Age-group rules Generally not recommended for children under 12 or 14 years, though some labels specify 5 mL to 10 mL for children 5–12 years.

Special Procedural Conditions

Entity Administration Constraint
Drug Separation A mandatory two-hour interval must be observed between the administration of this medicine and other oral medications to prevent interference with their absorption.

The use of the medicine is an oral, short-term treatment scheduled according to meal times and symptoms. This framework utilizes standardized administration quantities and includes a two-hour separation requirement from other oral drugs. These instructions define the method of consumption.

Recent Clinical Evidence

Overview of Studies

Magnesium trisilicate is an inorganic compound primarily studied for its antacid properties in managing symptoms related to gastric hyperacidity, heartburn, and peptic ulcers. In the stomach, it acts as a neutralizing agent by reacting with gastric acid, increasing the stomach's pH. It also forms a colloidal silica precipitate that may offer a protective coating to the gastrointestinal mucosa.

Tolerability and Safety Profile

Clinical data and long-term use reports generally describe magnesium trisilicate as having an acceptable tolerability profile, especially when used for its approved indications. The most frequently observed adverse event related to the magnesium content is diarrhea, while the aluminum content (when used in combination) is more commonly associated with constipation. These effects can sometimes be balanced in combination antacid formulas. Concerns around long-term accumulation of magnesium or silicate are typically focused on individuals with pre-existing renal impairment, as clearance of magnesium is proportional to kidney function.

Combination Research

Research often investigates magnesium trisilicate as part of combination therapies, frequently paired with aluminum hydroxide to balance the individual side effects (diarrhea from magnesium, constipation from aluminum). Other studies have explored its use alongside alginates and hyaluronic acid in managing Gastroesophageal Reflux Disease (GERD). These comparative trials aim to evaluate whether the combined components—antacid, mucosal protectant, and foaming agent—result in enhanced symptomatic relief versus placebo or individual components. Further research continues to examine its interactions with other orally administered medications, particularly those where altered gastric pH or cationic binding might affect drug absorption.

Frequently Asked Questions (FAQ)

Common questions about Magnesium Trisilicate (FAQ)


Q: How quickly does Magnesium Trisilicate start to work for stomach acid?

A: Official pharmacological descriptions note that Magnesium Trisilicate has a slow onset of action compared to some other antacids. This means it may take longer to feel initial relief, but the effect is generally described as sustained over a longer period.


Q: How long does the effect of Magnesium Trisilicate typically last?

A: Pharmacological profiles indicate that Magnesium Trisilicate is associated with a long-lasting duration of effect. This is due to its dual mechanism, which includes both sustained acid neutralization and the formation of a physical, protective silica layer in the stomach.


Q: Can Magnesium Trisilicate cause changes in bowel movements, like constipation or diarrhea?

A: Regulatory documents list changes in bowel movements as possible undesirable effects. Diarrhea is commonly associated with the magnesium content of the medicine. While the standalone product is less associated with it, constipation may also be reported, particularly when the drug is used in combination products that contain aluminum.


Q: Is it possible to be allergic to Magnesium Trisilicate?

A: Official product labeling lists hypersensitivity or allergic reaction to magnesium trisilicate or its excipients as a possible reaction. Hypersensitivity is mentioned in the official labeling, and any persistent or severe adverse effect should be discussed with a healthcare provider.


Q: Why is there a specific warning about phosphate levels with this drug?

A: One of the conditions listed in official documents that makes this drug unsuitable for use is hypophosphataemia (very low phosphate levels). Regulatory warnings indicate that aluminum-containing antacids (often combined with this drug) can potentially lead to phosphate depletion with prolonged use, which is why hypophosphataemia is listed as a contraindication.


Q: What kind of studies have been done on Magnesium Trisilicate and pregnancy?

A: Official regulatory documents indicate that only limited data are available on the use of this antacid during human pregnancy. Some sources note that the prolonged or high-dose use of magnesium trisilicate is generally not recommended. The use of any medication during pregnancy is a topic that requires discussion with a healthcare provider.


Q: Is it true that Magnesium Trisilicate can interfere with the absorption of certain antibiotics?

A: Yes, official drug interaction sections confirm that this product can reduce the absorption and therefore the effectiveness of certain orally administered antibiotics. This includes drug classes such as Tetracyclines and Quinolones.


Q: What are the least common, but still reported, side effects?

A: In addition to the most common side effect (diarrhea) and more serious effects (like high magnesium levels), regulatory documents list other adverse events. These less common side effects may include nausea, vomiting, abdominal discomfort, headache, and dizziness.


Q: Can people with diabetes use Magnesium Trisilicate safely?

A: Regulatory documents do not specifically prohibit use in people with diabetes. However, official warnings caution against use in patients with hereditary sugar intolerances if the formulation contains certain sugar excipients (inactive ingredients), which is a factor to consider when reading the product label.


Q: Is Magnesium Trisilicate the same as Milk of Magnesia?

A: No, they are different chemical compounds used for similar purposes. Magnesium Trisilicate is a hydrated silicon and magnesium oxide, while Milk of Magnesia is the common name for the antacid Magnesium Hydroxide.


Q: Is it normal to feel bloated after taking Magnesium Trisilicate?

A: While regulatory lists may not always feature bloating as a common side effect, official reports do include general abdominal discomfort as a possible undesirable effect. Any symptom that is severe or persistent should be discussed with a healthcare provider.


Q: What happens to the magnesium and silicate in the body after taking this medicine?

A: The drug's primary action is local and non-systemic within the digestive tract. Pharmacokinetic data show that most of the compound is not absorbed. However, a small portion—approximately 5% of the magnesium—may enter the bloodstream and is then excreted by the kidneys. Traces of the resulting silica are also excreted in the urine.


Q: Can someone who is lactose intolerant use Magnesium Trisilicate?

A: Regulatory documents advise caution for those with conditions like LAPP lactase deficiency or other hereditary sugar intolerances. This specific warning depends entirely on whether the individual product formulation contains lactose or other related sugars as inactive ingredients (excipients). If a patient has a known intolerance, checking the product's excipients list is generally advised.


Q: What is the difference between magnesium hydroxide and magnesium trisilicate?

A: Both compounds are different inorganic salts that are officially classified as antacids. Regulatory information shows that while both neutralize stomach acid, they have different chemical structures and may offer different characteristics in terms of the onset and duration of their acid-reducing effect.


Q: Why is it called a 'trisilicate'?

A: The term trisilicate is a chemical naming convention used to define the ratio of silicon (silicate) atoms to oxygen in the chemical structure of the active ingredient, Mg2 Si3 O8 cdot x H2 O.


Q: Can I use Magnesium Trisilicate if I have a history of kidney stones?

A: Regulatory cautions advise that very high intake, when used for prolonged periods, has been associated with the formation of silica-based kidney stones. Individuals with a pre-existing history of kidney stone formation may need to consider this factor when evaluating use.


Q: Why is hydration sometimes mentioned when talking about Magnesium Trisilicate use?

A: Official administration guidelines for the liquid or powder forms often specify taking the dose in water or with a full glass of water. This is done to ensure the correct suspension or dilution of the medicine for proper activity and efficient neutralization of gastric acid.


Q: Does Magnesium Trisilicate contain aluminum?

A: The standalone active ingredient, Magnesium Trisilicate, does not chemically contain aluminum. However, it is frequently formulated in combination products that intentionally include aluminum hydroxide to help balance the individual side effects, such as the diarrhea associated with magnesium.


Q: Does Magnesium Trisilicate have a chalky or noticeable taste?

A: The liquid form is officially a viscous suspension, and manufacturers often add excipients (inactive ingredients) like flavorings (such as peppermint) to the preparation. This is done to improve the palatability and manage the texture of the product.


Q: Is Magnesium Trisilicate sometimes used in combination products?

A: Yes, official product information and research reviews confirm that it is frequently utilized in combination products. It is most commonly paired with aluminum hydroxide to help manage side effects and may also be combined with other components like alginates.


Q: Can I use Magnesium Trisilicate if I am taking vitamin supplements?

A: Official regulatory warnings mandate a two-hour separation interval from all other orally administered medications or supplements. This is to prevent the antacid from interfering with the absorption of the other substances, which would include vitamin or mineral supplements.


Q: Does Magnesium Trisilicate have any impact on blood pressure?

A: The drug's primary action is local, but high blood levels of magnesium (hypermagnesemia) can occur with overdose or in patients with impaired kidney function. Symptoms of this condition, as listed in official documents, include hypotension (low blood pressure).


Q: What should I do if I accidentally take more than the amount suggested?

A: Regulatory documents advise that in case of overdose, patients should be monitored for signs of high magnesium levels (hypermagnesemia) and metabolic alkalosis. Official documentation advises that in cases of suspected overdose, monitoring for signs of hypermagnesemia is required, and professional medical attention may be necessary.


Q: What are the signs that I might be taking too much Magnesium Trisilicate?

A: Symptoms of high magnesium levels (hypermagnesemia) resulting from excessive intake are listed in official documents. These can include nausea, vomiting, confusion, drowsiness, muscle weakness, and low blood pressure. These symptoms are listed in official documents, and any new or worsening serious symptoms should be promptly discussed with a healthcare provider.


Q: Does taking Magnesium Trisilicate long-term cause any problems?

A: Official warnings state that prolonged or excessive use is not recommended without medical supervision. Long-term use may lead to serious concerns, particularly the risk of high magnesium levels (hypermagnesemia) or the potential formation of silica kidney stones.


Q: Is the action of Magnesium Trisilicate local to the stomach, or does it have whole-body effects?

A: The drug's primary pharmacological action is non-systemic, meaning it is local to the stomach where it neutralizes acid and forms a protective coating. However, a small portion of the magnesium is absorbed, and if high levels build up (especially in kidney disease), this can cause systemic effects like muscle weakness and low blood pressure.


Q: Why is it important to follow the recommended water intake with the powder form?

A: The recommendation to take the liquid or powder forms in water is a required step in the administration guidelines. This ensures the correct suspension or dilution of the active ingredient for proper activity and efficient gastric neutralization.

How should Magnesium Trisilicate be stored and disposed of?

How to Store and Dispose of Magnesium Trisilicate?

Storing Magnesium Trisilicate requires adherence to specific conditions documented in official regulatory labeling to maintain stability and effectiveness. The medicine must be kept in a dry and dark place, protected from both light and moisture.

Temperature requirements mandate that the product is stored at controlled room temperature, typically below 25 C or 30 C depending on the specific label, and kept in its original unopened container until use.

A key handling requirement is to always store the medication safely, out of the reach and sight of children and pets, to prevent accidental ingestion. For disposal, any unused medicine must be thrown away after the expiration date printed on the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Magnesium Trisilicate found in:

A-Z Index: